Phase 2 study of anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation

• Main Authors: Maertens, J, Logan, AC, Jang, J, Long, G, Tang, JL, Hwang, WYK, Koh, LP, Chemaly, R, Gerbitz, A, Winkler, J, Yeh, SP, Hiemenz, J, Christoph, S, Lee, DG, Wang, PN, Holler, E, Mielke, S, Akard, L, Yeo, A, Ramachandra, S, Smith, K, Pertel, P, Segal, F
• Other Authors: MEDICINE
• Format: Article
• Published: American Society for Microbiology 2022
• Subjects: hematopoietic stem cell transplantation; human cytomegalovirus; prophylaxis; Administration, Intravenous; Adult; Aged; Antibodies, Viral; Antiviral Agents; Cytomegalovirus Infections; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Placebos; Treatment Outcome; Viral Load; Young Adult
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/228766
• Institution: National University of Singapore

10.1128/AAC.02467-19